Welcome to our dedicated page for Selectquote SEC filings (Ticker: SLQT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SelectQuote, Inc. filings document formal disclosures for a public insurance distribution and healthcare services company. Recent Form 8-K reports furnish quarterly and annual operating results, investor presentation exhibits, and segment information for Senior, Healthcare Services, Life, and SelectRx-related activity.
The company’s regulatory filings also cover capital-structure matters, including a senior secured credit facility and revolving credit facility, as well as NYSE continued-listing compliance disclosures. Governance records include annual meeting voting results for director elections, auditor ratification, and advisory executive-compensation matters, while amended event reports document corrections to previously furnished earnings materials.
SelectQuote reported strong quarterly results with higher revenue and a sharp jump in profitability. For the three months ended December 31, 2025, revenue rose to $537.1 million from $481.1 million, driven largely by growth in its Healthcare Services pharmacy business, which increased to $227.2 million from $180.0 million.
Net income improved to $69.3 million versus $53.2 million a year earlier, helped by a $19.3 million favorable change in warrant fair value and lower interest expense. After paying and accruing $18.1 million of dividends and accretion on its Senior Non-Convertible Preferred Stock, net income attributable to common shareholders was $51.2 million.
For the first six months of the fiscal year, revenue reached $865.9 million, up from $773.3 million, and net income climbed to $38.8 million from $8.7 million. Operating cash flow remained negative at $(21.6) million, while total debt increased to $405.8 million and preferred stock carried a liquidation preference of $394.2 million.
SelectQuote, Inc. furnished an update on its business by reporting financial results for the second quarter ended December 31, 2025. The company used a press release and an investor presentation, attached as Exhibits 99.1 and 99.2, to present these results.
The information in these exhibits was furnished, not filed, meaning it is not subject to certain Exchange Act liabilities and is only incorporated into other SEC documents if specifically referenced.
SelectQuote, Inc. entered into a new senior secured credit agreement on January 8, 2026, providing a $325 million senior secured term loan and a $90 million senior secured revolving credit facility. About $313.8 million of the term loan proceeds were used to fully repay all outstanding amounts under the company’s previous credit facility, with the balance and the revolver available for working capital and other general corporate purposes.
The term loan bears interest at either SOFR, with a 3.00% floor, plus 6.50% or a base rate plus 5.50%, and amortizes quarterly at 0.625% of the initial principal amount until June 30, 2027, and 1.25% thereafter. The revolving credit facility bears interest at either SOFR, with a 3.00% floor, plus 4.00% or a base rate plus 3.00%, and includes capacity for up to $5.0 million in letters of credit. The new facility is secured by substantially all assets of SelectQuote and certain subsidiaries, includes financial covenants on fixed charge coverage and liquidity, and replaces the prior Ares-led credit agreement, which was terminated on the closing date.
SelectQuote reported voting results from its 2025 Annual Meeting. Two Class III directors were elected: Denise L. Devine (65,350,226 votes for; 17,656,400 withheld) and Donald L. Hawks III (67,920,342 for; 15,086,284 withheld). Stockholders also ratified Deloitte & Touche LLP as independent auditor with 112,814,953 votes for, 1,156,892 against, and 472,083 abstentions.
The advisory vote on executive compensation passed with 79,848,312 votes for, 3,006,318 against, and 151,996 abstentions. A total of 114,443,928 shares were represented in person or by proxy, out of 175,884,846 shares outstanding as of the September 23, 2025 record date.
SelectQuote (SLQT) director reported equity changes on 11/11/2025. 52,631 restricted stock units vested in full and converted into common stock at $0. The director also received a new grant of 106,250 RSUs that will vest in full on the date of the Company’s 2026 Annual Meeting of Stockholders, subject to continued Board service. Following the transactions, the director holds 363,214 shares directly and 38,500 shares indirectly through Devanny LLC.
SelectQuote (SLQT) director Mr. Hawks reported equity transactions on 11/11/2025. 52,631 restricted stock units vested and were settled into common stock at a stated price of $0, and he now directly holds 513,214 shares.
He also received a new grant of 106,250 restricted stock units that vest in full on the date of the Company’s 2026 Annual Meeting of Stockholders, subject to continued Board service. Separately, the filing lists indirect holdings of 8,877,872 shares owned by BEP III LLC, 6,911,600 shares owned by BEP III Co-Invest LLC, and 1,889,285 shares owned by SQ Co-investors LLC, with a pecuniary-interest disclaimer.
SelectQuote, Inc. (SLQT) reported insider equity activity by a director on 11/11/2025. The filing shows 52,631 shares of common stock were acquired at $0 upon settlement of previously awarded RSUs (code M), bringing the director’s directly held shares to 371,214 after the transaction.
On the same date, the director received a new award of 106,250 restricted stock units under the 2020 Omnibus Incentive Plan. According to the terms, the award will vest in full on the date of the Company’s 2026 Annual Meeting of Stockholders, subject to continued Board service as of that date. Each RSU represents the right to receive one share of common stock.
SelectQuote, Inc. (SLQT) reported insider equity activity by a director. On 11/11/2025, 52,631 shares of common stock were acquired at $0 following the vesting and settlement of previously granted restricted stock units (transaction code M). After this event, beneficial ownership stood at 363,214 common shares, held directly.
The filing also reports a new award of 106,250 restricted stock units granted on 11/11/2025 (transaction code A). According to the award terms, these RSUs vest in full on the date of the Company’s 2026 Annual Meeting of Stockholders, subject to continued Board service.
SelectQuote (SLQT) Form 4: A director reported equity changes on 11/11/2025. An RSU award vested and settled into 52,631 shares (code M, at $0), bringing directly held common shares to 513,214.
The director also received a new grant of 106,250 RSUs that vest in full on the Company’s 2026 Annual Meeting of Stockholders, subject to continued board service. Indirect beneficial holdings are listed as 8,877,872 (BEP III LLC), 6,911,600 (BEP III Co‑Invest LLC), and 1,889,285 (SQ Co‑investors LLC), with a footnote limiting beneficial ownership to pecuniary interests.
SelectQuote, Inc. (SLQT) reported an insider equity award. A director received 106,250 restricted stock units (RSUs) on 11/11/2025 under the Company’s 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of common stock, par value $0.01 per share.
The RSUs vest in full on the date of the Company’s 2026 Annual Meeting of Stockholders, subject to continued board service through that date. Following the grant, the reporting person beneficially owns 106,250 shares on a direct basis.